MedImmune has formed a partnership with the National Cancer Institute to develop cancer therapies that use the immune system or attack tumor cells to fight the disease.
MedImmune has formed a partnership with the National Cancer Institute to develop cancer therapies that use the immune system or attack tumor cells to fight the disease.